FMO5 and Hypertension: The upregulation of ACE and ACE2 enzymes, and of AT1 receptors, among a downregulation of AT2, Mas and MrgD receptors, have an impact in NADPH oxidase expression, and thus, influence the redox status and contribute to vascular remodeling and fibrosis associated with hypertension.